Human Molecular Genetics, 2000, Vol. 9, No. 12 1787-1793
© 2000 Oxford University Press
A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity
1Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA, 2Division of Human Genetics, Children’s Hospital Medical Center, Cincinnati, OH 45229, USA and 3Ahmanson Department of Pediatrics, Steven Spielberg Pediatric Research Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
The A1555 G mutation in mitochondrial 12S rRNA has been found to be associated with non-syndromic deafness and aminoglycoside-induced deafness. The sensitivity to the aminoglycoside paromomycin has been analyzed in lymphoblastoid cell lines derived from five deaf individuals and five hearing individuals from an Arab-Israeli family carrying the A1555G mutation, and three married-in controls from the same family. Exposure to a high concentration of paromomycin (2 mg/ml), which caused an 8% average increase in doubling time (DT) in the control cell lines, produced higher average DT increases (49 and 47%) in the A1555G mutation-carrying cell lines derived from symptomatic and asymptomatic individuals, respectively. The ratios of translation rates in the presence and absence of paromomycin, which reflected the effect of the drug on mitochondrial protein synthesis, were significantly decreased in the cell lines derived from symptomatic and asymptomatic individuals (by 30 and 28% on average, respectively), compared with the ratios in the control cell lines. These ratios showed, in both groups of mutant cell lines, a significant negative correlation with the ratios of DTs in the presence and absence of the antibiotic. These results have provided the first direct evidence that the mitochondrial 12S rRNA carrying the A1555G mutation is the main target of aminoglycosides. They suggest that these antibiotics exert their detrimental effect through an alteration of mitochondrial protein synthesis, which exacerbates the inherent defect caused by the mutation, reducing the overall translation rate down to and below the minimal level required for normal cellular function (40–50%).
+ To whom correspondence should be addressed at: Division of Human Genetics, Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA. Tel: +1 513 636 3337; Fax: +1 513 636 2261; Email: guar6n@chmcc.org
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Du, R. Damoiseaux, S. Nahas, K. Gao, H. Hu, J. M. Pollard, J. Goldstine, M. E. Jung, S. M. Henning, C. Bertoni, et al. Nonaminoglycoside compounds induce readthrough of nonsense mutations J. Exp. Med., September 28, 2009; 206(10): 2285 - 2297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cotney, S. E. McKay, and G. S. Shadel Elucidation of separate, but collaborative functions of the rRNA methyltransferase-related human mitochondrial transcription factors B1 and B2 in mitochondrial biogenesis reveals new insight into maternally inherited deafness Hum. Mol. Genet., July 15, 2009; 18(14): 2670 - 2682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Hobbie, C. M. Bruell, S. Akshay, S. K. Kalapala, D. Shcherbakov, and E. C. Bottger Mitochondrial deafness alleles confer misreading of the genetic code PNAS, March 4, 2008; 105(9): 3244 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Du, X. Liu, E. M. Welch, S. Hirawat, S. W. Peltz, and D. M. Bedwell PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model PNAS, February 12, 2008; 105(6): 2064 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pye, D. S. Kyriakouli, G. A. Taylor, R. Johnson, M. Elstner, B. Meunier, Z. M. A. Chrzanowska-Lightowlers, R. W. Taylor, D. M. Turnbull, and R. N. Lightowlers Production of transmitochondrial cybrids containing naturally occurring pathogenic mtDNA variants Nucleic Acids Res., August 2, 2006; 34(13): e95 - e95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Yan, X. Li, G. Faye, and M.-X. Guan Mutations in MTO2 Related to tRNA Modification Impair Mitochondrial Gene Expression and Protein Synthesis in the Presence of a Paromomycin Resistance Mutation in Mitochondrial 15 S rRNA J. Biol. Chem., August 12, 2005; 280(32): 29151 - 29157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhao, W.-Y. Young, Q. Yan, R. Li, J. Cao, Q. Wang, X. Li, J. L. Peters, D. Han, and M.-X. Guan Functional characterization of the mitochondrial 12S rRNA C1494T mutation associated with aminoglycoside-induced and non-syndromic hearing loss Nucleic Acids Res., February 18, 2005; 33(3): 1132 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li and M.-X. Guan A Human Mitochondrial GTP Binding Protein Related to tRNA Modification May Modulate Phenotypic Expression of the Deafness-Associated Mitochondrial 12S rRNA Mutation Mol. Cell. Biol., November 1, 2002; 22(21): 7701 - 7711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, R. Li, X. Lin, and M.-X. Guan Isolation and Characterization of the Putative Nuclear Modifier Gene MTO1 Involved in the Pathogenesis of Deafness-associated Mitochondrial 12 S rRNA A1555G Mutation J. Biol. Chem., July 19, 2002; 277(30): 27256 - 27264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-X. Guan, N. Fischel-Ghodsian, and G. Attardi Nuclear background determines biochemical phenotype in the deafness-associated mitochondrial 12S rRNA mutation Hum. Mol. Genet., March 1, 2001; 10(6): 573 - 580. [Abstract] [Full Text] [PDF]
|
|